Page 12 - Caredx News Today

CareDx, Inc (NASDAQ:CDNA – Get Rating) Director Michael Goldberg sold 500 shares of the firm’s stock in a transaction that occurred on Monday, April 11th. The stock was sold at an average price of $36.01, for a total transaction of $18,005.00. Following the completion of the sale, the director now owns 62,267 shares in the […]

Russell Investments Group Ltd. lowered its position in shares of CareDx, Inc (NASDAQ:CDNA – Get Rating) by 63.8% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 21,706 shares of the company’s stock after selling 38,181 shares during the period. Russell Investments […]

Symposium, “Improved Precision with a Multimodality Approach,” Reviews Innovative Solutions for a More Holistic View of Allograft Health...

SOUTH SAN FRANCISCO, Calif., March 30, 2022 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA) - The Transplant Company focused on the discovery, development, and commercialization of clinically differentiated

SOUTH SAN FRANCISCO, Calif., March 30, 2022 -- CareDx, Inc. – The Transplant Company™ focused on the discovery, development, and commercialization of clinically differentiated,... | March 30, 2022

Analysts forecast that CareDx, Inc (NASDAQ:CDNA – Get Rating) will post earnings per share (EPS) of ($0.04) for the current quarter, Zacks reports. Three analysts have made estimates for CareDx’s earnings. CareDx posted earnings per share of $0.14 during the same quarter last year, which would indicate a negative year over year growth rate of […]

Represents World’s First Surveillance Solutions for Investigational Use in Xenotransplantation Research and Post-Xenotransplant Clinical Monitoring...

New Features Aim to Help More Patients with Kidney Failure Receive an Organ Transplant...

Jury Finds Natera Falsely Advertised its Prospera Kidney Transplant TechnologySOUTH SAN FRANCISCO, Calif., March 23, 2022 -- CareDx, Inc. , a leading precision medicine company focused on the... | March 23, 2022

SOUTH SAN FRANCISCO, Calif., March 16, 2022 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA) – The Transplant Company™ focused on the discovery,...